Colonoscopic Probiotics Spray in Irritable Bowel Syndrome

NANot yet recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Effect of Drug
Interventions
BIOLOGICAL

Colonscopic probiotics spray

20g of multi-strain probiotics powder via colonoscopic spray. The probiotic used in this study is SynPro-15G, which has 15 probiotics, including Bacillus coagulans BC1031, Bifidobacterium bifidum BB14, Bifidobacterium breve BR18, Bifidobacterium animalis subsp. lactis BAL06, Bifidobacterium longum (B. longum) BL986, Lactobacillus acidophilus LA1063, Lactobacillus casei LC122, Lactobacillus delbrueckii subsp. lactis LDL114, Lactobacillus fermentum LF26, Lactobacillus helveticus LH43, Lactobacillus paracasei LPC12, Lactobacillus plantarum LP198, Lactobacillus reuteri LR21, Lactobacillus rhamnosus LRH10, and Streptococcus thermophilus ST37 at a concentration of 2x1010 CFU/g (Synbiotech Corp., Kaohsiung, Taiwan). SynPro-15G is made either as a vial of powder (2x1011 CFU /vial) for colonoscopic spray or as a capsule (2x1010 CFU/capsule) for oral intake.

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

NCT05864716 - Colonoscopic Probiotics Spray in Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter